Back to FDA Applications sponsored by ALLERGAN

FDA Drug Application 020613 by ALLERGAN

Application Number020613
Application Type New Drug Application
Sponsor ApplicantALLERGAN
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP09/6/1996N       
AP05/29/1997SCS       
AP01/15/1998SCS       
AP02/25/1998SCS       
AP05/20/1998SCM       
AP012/13/1999SLR       
AP08/26/1999SCS       
AP012/13/1999SLR       
AP05/26/2000SCS       
AP010/2/2000SCM       
AP07/13/2001SCM       
AP04/9/2001SCM       
AP04/9/2001SCS       
AP05/14/2001SCM       
AP04/12/2001SCM       
AP012/4/2001SCM       
AP012/20/2001SE53865018   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-490S007_Brimonidine%20Tartrate%20Ophthalmic_Approv.pdf 12/20/2001
AP012/20/2001SE53866018   http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21262s6lbl.pdf 12/20/2001
AP012/20/2001SE58692018   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-490s007_Alphagan.cfm 5/27/2004
AP05/16/2002SCS       
AP04/12/2002SCM       
AP06/6/2013SCM       
AP03/23/2016SLR45504031   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020613Orig1s031ltr.pdf 3/25/2016
AP03/23/2016SLR45518031   http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020613s031lbl.pdf 3/29/2016




Back to FDA Applications sponsored by ALLERGAN